Login / Signup

Multiple myeloma extramedullary relapse at the sellar and suprasellar region after autologous stem cell transplantation.

Orlando De Jesus
Published in: Surgical neurology international (2024)
In the majority of MM patients with CNS involvement, ASCT did not prevent the development of EM sellar plasmacytomas. The IgA subtype is associated with more aggressive disease biology for CNS relapses.
Keyphrases
  • stem cell transplantation
  • multiple myeloma
  • high dose
  • blood brain barrier
  • bone marrow
  • cell therapy
  • low dose
  • platelet rich plasma
  • mesenchymal stem cells